Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-07 4:30 pm Purchase | 2026-03-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Trails Edge Capital Partners, LP | 2,409,638 6.000% | 2,409,638 (New Position) | Filing History |
| 2026-03-26 5:37 pm Sale | 2026-03-20 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Trails Edge Capital Partners, LP | 5,333,333 4.300% | -3,684,547 (-40.86%) | Filing History |
| 2026-02-25 4:15 pm Purchase | 2026-02-18 | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Trails Edge Capital Partners, LP | 126,010 9.900% | 126,010 (New Position) | Filing History |
| 2026-02-24 4:15 pm Purchase | 2026-02-17 | 13G | IMMUNIC INC IMUX | Trails Edge Capital Partners, LP | 11,454,000 8.700% | 11,454,000 (New Position) | Filing History |
| 2026-02-17 4:30 pm Purchase | 2025-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Trails Edge Capital Partners, LP | 5,227,222 5.800% | 2,910,069 (+125.59%) | Filing History |
| 2026-02-10 4:15 pm Purchase | 2026-02-03 | 13G | PROMIS NEUROSCIENCES INC N PMN | Trails Edge Capital Partners, LP | 933,477 9.900% | 933,477 (New Position) | Filing History |
| 2025-12-31 5:00 pm Purchase | 2025-12-23 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Trails Edge Capital Partners, LP | 6,145,198 5.100% | 6,145,198 (New Position) | Filing History |
| 2025-12-31 5:00 pm Purchase | 2025-12-24 | 13G | LB PHARMACEUTICALS INC LBRX | Trails Edge Capital Partners, LP | 1,268,265 5.000% | 1,268,265 (New Position) | Filing History |
| 2025-12-15 6:00 pm Purchase | 2025-12-08 | 13G | NEUROGENE INC NGNE | Trails Edge Capital Partners, LP | 785,000 5.100% | 785,000 (New Position) | Filing History |
| 2025-11-14 4:05 pm Purchase | 2025-09-30 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Trails Edge Capital Partners, LP | 9,017,880 9.900% | 169,998 (+1.92%) | Filing History |
| 2025-09-08 6:00 pm Purchase | 2025-08-29 | 13G | VTV THERAPEUTICS INC VTVT | Trails Edge Capital Partners, LP | 340,536 9.900% | 340,536 (New Position) | Filing History |
| 2025-08-18 5:00 pm Purchase | 2025-08-11 | 13G | X4 PHARMACEUTICALS INC XFOR | Trails Edge Capital Partners, LP | 2,317,153 9.900% | 2,317,153 (New Position) | Filing History |
| 2025-07-21 4:30 pm Purchase | 2025-07-14 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Trails Edge Capital Partners, LP | 8,847,882 9.900% | 8,847,882 (New Position) | Filing History |